[Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with the keratoconjunctivitis sicca of Sjögren's syndrome].
D005353:Fibronectins / Q000008:administration & dosage* / Q000097:blood / Q000302:isolation & purification; D006801:Humans; D007637:Keratoconjunctivitis / Q000628:therapy*; D007638:Keratoconjunctivitis Sicca / Q000628:therapy*; D009883:Ophthalmic Solutions; D012859:Sjogren's Syndrome / Q000628:therapy*
D005353:Fibronectins; D009883:Ophthalmic Solutions